Agnes Yong

Dr, MBBCh (Hons), PhD, MRCP (UK), FRCPath, FRCPA

  • 2509 Citations
  • 27 h-Index
1994 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Public Profile

Associate Professor Agnes Yong completed undergraduate and post-graduate medical training in the UK. She continued subspecialty training in haematology and haematopoietic cell transplantation (HCT) at the Hammersmith Hospital, London. Following her PhD on the molecular heterogeneity of chronic myeloid leukaemia (CML), she was a post-doctoral fellow at the National Heart, Lung and Blood Institute at the National Institutes of Health, Bethesda, Maryland. She was involved in studies characterising immune responses to tumour-associated antigens WT1, proteinase 3, PRAME and BMI-1, and co-investigator on clinical trials of peptide vaccine therapy in leukaemia. Her research interests include CML, mechanisms of inherent leukaemia immunogenicity and studies to enhance anti-leukaemia immune responses whether in the setting of an allogeneic HCT with the graft-versus-leukaemia effect, or in an autologous setting against tumour-associated antigens. She is interested in furthering cellular and immunotherapy for treatment of haematological malignancies, and is involved in ongoing clinical and laboratory studies on CML, multiple myeloma, graft-versus-leukaemia, and adoptive T cell therapy in Adelaide. Her research group’s funding sources include grants from the Leukaemia Foundation, Beat Cancer Hospital Research Package/Cancer Council SA and NH&MRC.

External positions

Consultant Haematologist, Adelaide Cancer Centre

Associate Professor, University of Adelade

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Lineage of measurable residual disease in patients with chronic myeloid leukemia in treatment-free remission

Pagani, I., Dang, Y., Saunders, V., Grose, R., Shanmuganathan, N., Kok, C., Carne, L., Rwodzi, Z., Watts, S., McLean, J., Braley, J., Altamura, H., Yeung, D., Branford, S., Yong, A., White, D., Hughes, T. & Ross, D., 1 Apr 2020, In : Leukemia. 34, 4, p. 1052-1061 10 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia

Ross, D. M., Pagani, I., Irani, Y., Clarson, J., Gray, T., Dang, Y., McLean, J., Saunders, V., Carne, L., Reynolds, J., Ritchie, D. S., White, D., Branford, S., Hughes, T. & Yong, A., 1 Aug 2019, In : British Journal of Haematology. 186, 3, p. e56-e60

Research output: Contribution to journalLetter

4 Citations (Scopus)

Modeling the safe minimum frequency of molecular monitoring for CML patients attempting treatment-free remission

Shanmuganathan, N., Braley, J. A., Yong, A., Hiwase, D., Yeung, D., Ross, D., Hughes, T. & Branford, S., 4 Jul 2019, In : Blood. 134, 1, p. 85-89 5 p.

Research output: Contribution to journalLetter

5 Citations (Scopus)

Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis

Wood, W. A., Brazauskas, R., Hu, Z. H., Abdel-Azim, H., Ahmed, I. A., Aljurf, M., Badawy, S., Beitinjaneh, A., George, B., Buchbinder, D., Cerny, J., Dedeken, L., Diaz, M. A., Freytes, C. O., Ganguly, S., Gergis, U., Almaguer, D. G., Gupta, A., Hale, G., Hashmi, S. K. & 30 others, Inamoto, Y., Kamble, R. T., Adekola, K., Kindwall-Keller, T., Knight, J., Kumar, L., Kuwatsuka, Y., Law, J., Lazarus, H. M., LeMaistre, C., Olsson, R. F., Pulsipher, M. A., Savani, B. N., Schultz, K. R., Saad, A. A., Seftel, M., Seo, S., Shea, T. C., Steinberg, A., Sullivan, K., Szwajcer, D., Wirk, B., Yared, J., Yong, A., Dalal, J., Hahn, T., Khera, N., Bonfim, C., Atsuta, Y. & Saber, W., Sep 2018, In : Biology of Blood and Marrow Transplantation. 24, 9, p. 1928-1935 8 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)